Real-World Effectiveness of Bebtelovimab Versus Nirmatrelvir/Ritonavir in Outpatients with COVID-19
2024 · Pulmonary Therapy · 1 citations
https://doi.org/10.1007/s41030-024-00284-w
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
246
Citations
5
h-index
2
i10-index
Jennifer M. Alyea is an academic researcher from Eli Lilly (United States). The author has contributed to research in topics: Cancer survivorship and care & Cancer-related cognitive impairment studies & Mindfulness and Compassion Interventions. The author has an h-index of 5, co-authored 13 publications.
Click to start Chat